About Lifecare

We aim to complete the development, testing and introduction of the worlds first long term implantable micro sensor to give people with diabetes the modern tool they deserve for monitoring glucose levels.

Detecting glucose by the principle of the osmotic pressure holds promise of a glucose sensing technology that is suitable for both miniaturization and long term continuous monitoring in vivo without causing patient discomfort or reducing quality of life. It also offers several major advantages compared to current blood glucose measurement technologies.

The company

Our headquarter is located in Bergen, Norway. The research and development is performed through our research partner across Europe.

Lifecare AS (Ltd.) is listed on Oslo Stock Exchange (LIFE-ME), and has been dedicated to the research and development of medical sensors for health monitoring since 06/07.

The project

The Sencell-technology is protected by patents owned by Lifecare AS (LIFE-ME). These patents are granted until year 2030 and new patents are pending.

Proof of concept of the proprietary osmotic pressure sensing technology has been successfully performed in two preclinical trials 2016 – 2017, proving that the pressure technology is able to track interstitial glucose and providing stable references.

Further miniaturization of the injectable glucose sensor highlights the planned device evolution and the accuracy of the employed 3D nanosensor technology measurement system. Data shows that the Sencell technology probably employs the smallest MEMS based pressure sensor in the world, with a reliable reproducibility of measurement results and a pressure resolution, which should lead to a resolution of glucose differences higher than CGM-devices currently on the market.

Lifecare is now continuing the development of a wireless sensor prototype suitable for first long term human clinical.


  • Member of the Lifecare BoD from 2011 to 2020
  • Previously held senior management, operational and director positions in several internationally active companies.
  • Chairman of Osmotex AG, Switzerland
  • Experienced leading R&D companies to the commercial stage.
  • Licensed as Attorney at law in Norway
Prof. Dr. med. Dr. rer. nat. Andreas Pfützner
  • Managing Director of PFÜTZNER Science & Health Institute GmbH, Diabetes Center & Practice, Mainz/Germany, since 2013
  • Honorary Professor of Applied Clinical Research for the University of Applied Sciences, Bingen/Germany, since 2007
  • Over 25 years of pharmaceutical and device development experience
Dr. rer. nat. Frank Flacke
  • International operating consultant for drug and device development, strategy as well as clinical and medical affairs in the medtech and pharma business.
  • Previously global Medical Director Devices in the diabetes division at Sanofi
  • Held management positions in several biotech and technology companies.
  • Over 20 years of experience in the pharma and medtech business
Dr. Konstantin Kloppstech
VP Technology
  • CEO of DEVmedical UG, Oldenburg Germany
  • Senior Consultant Sensor Solutions
  • Head of Technology for MEMS/NEMS Sensor Development for Medical and Industrial Sensor Solutions 2016-2019
  • PhD at the Department of Physics in Sensor Development for Fundamental Research at University of Oldenburg, Oldenburg/Germany 2011-2015
Dr. rer. nat. Sanja Ramljak
QA/QC Manager
  • Scientific Project Manager sciema UG, Mainz/Germany, since 2014
  • Post Doctoral Fellow at German Primate Centre, Göttingen/Germany, 2008 - 2010
  • PhD at the Department of Neurology, Georg-August-University, Göttingen/Germany, 2003 – 2007

Board of directors

Christian Hysing-Dahl
Chairman of the board
  • Private investor & adviser
  • Former CEO & partner at Borea
  • Head of Norwegian Equities at Nordea Invest Mgmt.
  • Portfolio manager at DNB
  • Portfolio manager at Investa
  • Board member in several companies
Morten Foros Krohnstad
Deputy chairman

Kronstad is a partner in the law firm Schjødt and has extensive experience as a business lawyer with main areas of work in M&A and corporate, including corporate litigation. He serves on a number of boards as chairman and board member in Norwegian listed and un-listed companies.

Trine Teigland
Board member
  • MBA from University of St. Gallen (HSG)
  • Managed Swiss company Osmotex’ sales and marketing activities
  • Worked in Singapore for the world’s leading provider of integrated shipping services
  • BA in International Business with Chinese
Prof. Dr. Lutz Heinemann
Board member

Heinemann has a broad academic background with a special focus on research and development in insulin pharmacology and diabetes technology. Heinemann established the Profil Institute for Metabolic Research in Neuss, Germany in 2009 and since 2011 he has been Managing Editor of The Journal of Diabetes Science and Technology.

Bo Peterson
Board Member

Peterson holds a Ph.D. in Chemistry from The Technical University of Denmark. Peterson has over 20 years of work experience in developing diabetes technology products, most recently as Head of Diabetes Care at Cambridge Consultants, Cambridge, UK. Petersson is today also engaged as Chief Scientific Officer in RSP Systems A / S, Copenhagen, Denmark.

Scientific Advisory Board

Prof. David C. Klonoff
Chairman, Scientific Advisory Board
  • Clinical professor of Medicine, UCSF
  • Editor-in-chief, DST
  • Medical Director, INST
  • Chairman, i.a. DTM and ADA
  • Chaired i.e. FDA, NASA, US army, NIH, NSF
  • Consulting i.e. Sanofi, Google and Insulin
Prof. Lutz. Heinemann
Member, Scientific Advisory Board
  • Partner and Scientific Consultant, Profil
  • Co-editor, DST
  • Published 160 research articles
  • Awarded ”Leadership in Diabetes Technology”
  • Charing the EU founded project ”AP at home”
Prof. Kåre Birkeland
Member, Scientific Advisory Board
  • Professor of Internal Medicine and Endocrinology, University of Oslo
  • Senior consultant in Endocrinology, Dep. of Transplantation Medicine, Rikshospitalet, Oslo University Hospital
  • Chairman Advisory Board, Norwegian Diabetes Association
Prof. Dr. Michael Huth
Member, Scientific Advisory Board
  • Professor for experimental solid state physics
  • Stefan Lyson professor of physics
  • Member Board of Trustees Beilstein-Institut, Frankfurt am Main
  • Member Scientific Advisory Board Frankfurt Institute of Advanced Studies
  • Member Scientific Advisory Board Austrian Centre for Electron Microscopy and Nanoanalysis
  • Member Senate of the Goethe University, Frankfurt am Main
    - 170 peer-reviewed publications

Development partners

The research and development is performed through our research partner across Europe. Our partners are all rated global experts in their field.


We take our role in developing the next generation of diagnostics healthcare platform and sensor solutions seriously.

Digid is engaged in several research projects involving excellent international research partners as well as well-established technology providers.digid is developing a new kind of diagnostics healthcare platform solution through a proprietary combination of sensorics, biotech, A.I. and software that will, for the first time enable real-time identification of different biomarkers.

At the very core of digid ´s development, is a proprietary biosensor in combination with specifically designed receptors and digid´s Healthtech App as well as a fully integrated, A.I. powered Data Platform for real-time diagnostics of multiple human biomarkers.

This custom, real-time diagnostics procedure enables the identification of multiple human biomarkers in real-time and gives users / patients personalized recommendations on how to improve the current state of wellbeing. This can be a recommended doctor visit with a subsequent therapeutical treatment, specific nutritional supplements or other personalized recommendations to improve wellbeing and the current health-state

Visit website

Cambridge Consultants
United Kingdom

Cambridge Consultants (CC) is a world-class supplier of innovative product development engineering and technology consulting. Working from laboratories in Cambridge, UK, and Boston, USA, they have all the in-house skills needed to create an innovative concept right the way through to taking a product into manufacturing. Most of their projects deliver prototype hardware or software and trials production batches. Their technology consultants can help maximizing a product portfolio and technology roadmap.

CC works with some of the world’s largest blue-chip companies as well as with some of the smallest, innovative start-ups who want to change the status quo fast. Founded over 50 years ago, CC combines exceptional people, proven processes and excellent facilities, backed by an enviable track record of creating world-firsts, to deliver real value to our clients.

CC provides engineering product development services from idea conception to transfer to production to deliver innovative solutions with:

  • Reduced time to market

  • Increased return on investment

  • Reduced risk

Visit website

University of Bath

Research at the University of Bath is improving lives and changing the world we live in.

  • Ranked 6th in the UK by the Guardian University Guide 2020

  • Awarded Gold in the Teaching Excellence Framework 2017

  • 87% of our research is classed as world-leading or internationally excellent by the most recent Research Excellence Framework 2014

Visit website

PFÜTZNER Science & Health Institute

PFÜTZNER Science & Health Institute deliver research at the highest level, incl

  • Centre for clinical studies (phases II – IV)

  • Centre for medicinal/medical product studies (incl. CE studies)

  • Laboratory studies pursuant to ISO15197:2013 for blood glucose monitoring systems

  • Performance/preference studies for medical products

  • Strategy and performance of clinical investigations

Visit website